There was no such effect among people taking ACE inhibitors, AT II antagonists and beta blockers. Meier, PhD, MSc, with University Hospital Basel in Switzerland. Meier says more research is required to determine why calcium channel blockers may actually drive back Parkinson’s disease, whether that is a causal association indeed, and why the additional high blood pressure medications do not really offer a reduced risk.. Calcium channel blockers cut risk of Parkinson’s disease People taking a trusted group of drugs referred to as calcium channel blockers to treat high blood pressure also seem to be cutting their threat of Parkinson’s disease, according to a study published in the February 6, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.This is actually the third drug that is authorized since 2009 for the treating peripheral T-cell lymphoma, stated Richard Pazdur, M.D., director of any office of Hematology and Oncology Items in the FDA's Center for Drug Study and Evaluation. Today's authorization expands the amount of treatment options open to sufferers with serious and life-threatening diseases. Related StoriesOvarian cancer sufferers with a brief history of oral contraceptive make use of possess better outcomesNew RNA check of blood platelets may be used to detect area of cancerStudy shows uncommon HER2 missense mutations usually do not spread breasts cancer on the ownThe FDA granted accelerated acceptance to Folotyn in ’09 2009 for make use of in individuals with relapsed or refractory PTCL and Istodax in 2011 for the treating PTCL in sufferers who received at least one prior therapy.